Tom Gayner Mckesson Corp Transaction History

Markel Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 03, 2020	SELL	$125.49 - $164.68 $7.92 Million - $10.4 Million	-63,100 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$130.23 - $153.27 $390,689 - $459,810	3,000 Added 4.99%	63,100 $8.73 Million
Q3 2019 Nov 01, 2019	BUY	$134.24 - $148.53 $2.28 Million - $2.53 Million	17,000 Added 39.44%	60,100 $8.21 Million
Q2 2019 Aug 02, 2019	BUY	$112.47 - $134.93 $674,820 - $809,580	6,000 Added 16.17%	43,100 $5.79 Million
Q2 2018 Aug 03, 2018	BUY	$133.4 - $158.13 $933,800 - $1.11 Million	7,000 Added 23.26%	37,100 $4.95 Million

Q1 2018 Apr 27, 2018	BUY	$138.75 - $176.72 $555,000 - $706,880	4,000 Added 15.33%	30,100 $4.24 Million
Q3 2017 Oct 27, 2017	BUY	$146.0 - $161.87 $3.81 Million - $4.22 Million	26,100	26,100 $4.01 Million

1,688

109M

676K

678K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $83.1B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Markel Corp, based on Form 13F filings with the SEC.

Stay updated on Markel Corp and Tom Gayner with notifications on news.